Sister chromatid exchange and proliferation pattern in stimulated lymphocytes of cutaneous malignant melanoma patients. 1985

E Privitera, and A Ghidoni, and E Raimondi, and D Rovini, and M T Illeni, and N Cascinelli

Sister chromatid exchange (SCE) and the proliferative pattern of phytohemagglutinin-stimulated lymphocytes were examined in 36 nonfamilial cutaneous malignant melanoma (CMM) patients. One close relative of each of 27 CMM patients was also examined. All the patients had undergone surgical treatment for the neoplasm, but had received no chemotherapy or radiotherapy. The SCE rates were found to be higher and more variable in a significant fraction of CMM patients, and in relatively fewer unaffected relatives, which is in contrast to findings in unrelated subjects taken as controls. Also, variable and higher proportions of cells in metaphase of the first cell cycle (M1), after 72-hr culture in the presence of bromodeoxyuridine, were more often found among the CMM patients than in the controls; however, no effect of clinical progression of the neoplastic disease on SCE rates or on the lymphoproliferative pattern was observed. The present study indicates heterogeneity among subjects who develop CMM and suggests that the peculiarities of SCE rates and of the lymphoproliferative patterns observed in some of the CMM patients and in a few of their close relatives may be connected with the mechanism of onset of the neoplasm.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

E Privitera, and A Ghidoni, and E Raimondi, and D Rovini, and M T Illeni, and N Cascinelli
October 1978, Human genetics,
E Privitera, and A Ghidoni, and E Raimondi, and D Rovini, and M T Illeni, and N Cascinelli
June 1991, Cancer genetics and cytogenetics,
E Privitera, and A Ghidoni, and E Raimondi, and D Rovini, and M T Illeni, and N Cascinelli
August 1989, Cancer genetics and cytogenetics,
E Privitera, and A Ghidoni, and E Raimondi, and D Rovini, and M T Illeni, and N Cascinelli
September 1983, American journal of human genetics,
E Privitera, and A Ghidoni, and E Raimondi, and D Rovini, and M T Illeni, and N Cascinelli
May 1984, Lancet (London, England),
E Privitera, and A Ghidoni, and E Raimondi, and D Rovini, and M T Illeni, and N Cascinelli
May 1990, Mechanisms of ageing and development,
E Privitera, and A Ghidoni, and E Raimondi, and D Rovini, and M T Illeni, and N Cascinelli
October 1984, Cancer genetics and cytogenetics,
E Privitera, and A Ghidoni, and E Raimondi, and D Rovini, and M T Illeni, and N Cascinelli
January 1990, Medycyna pracy,
E Privitera, and A Ghidoni, and E Raimondi, and D Rovini, and M T Illeni, and N Cascinelli
August 1977, Journal of medical genetics,
E Privitera, and A Ghidoni, and E Raimondi, and D Rovini, and M T Illeni, and N Cascinelli
August 1977, Cellular immunology,
Copied contents to your clipboard!